Make Better Decisions - Finding and Evaluating Generic and Branded Drug Market Entry Opportunities

Get the Book: Make Better Decisions

Finding and Evaluating Generic and Branded Drug Market Entry Opportunities

PDF eBook: Just $10 Get Print Book on Amazon

Serving leading biopharmaceutical companies globally:

Boehringer Ingelheim
Merck
Medtronic
Express Scripts
Harvard Business School
Baxter

Last Updated: November 21, 2019

DrugPatentWatch Database Preview

Phendimetrazine tartrate - Generic Drug Details

See Plans and Pricing

« Back to Dashboard

What are the generic sources for phendimetrazine tartrate and what is the scope of patent protection?

Phendimetrazine tartrate is the generic ingredient in nineteen branded drugs marketed by Valeant, Numark, Graham Dm, Virtus Pharms, Shire Richwood, Mast Mm, Sandoz, Vitarine, Solvay, Teva, Ferndale Labs, Abc Holding, Camall, Chartwell Rx, Pvt Form, Forest Pharms, Barr, Elite Labs Inc, Inwood Labs, Ivax Pharms, Ivax Sub Teva Pharms, Kv Pharm, Kvk Tech, Mfg Chemists, Mikart, Nexgen Pharma Inc, Upsher Smith Labs, Usl Pharma, Watson Labs, and Wyeth Ayerst, and is included in ninety-six NDAs. Additional information is available in the individual branded drug profile pages.

There are five drug master file entries for phendimetrazine tartrate. Twenty-three suppliers are listed for this compound.

Drug Prices for phendimetrazine tartrate

See drug prices for phendimetrazine tartrate

Pharmacology for phendimetrazine tartrate
Synonyms for phendimetrazine tartrate
(2R,3R)-2,3-bis(oxidanyl)butanedioic acid; (2S,3S)-3,4-dimethyl-2-phenyl-morpholine
(2R,3R)-2,3-dihydroxybutanedioic acid; (2S,3S)-3,4-dimethyl-2-phenylmorpholine
(2S,3S)-3,4-Dimethyl-2-phenylmorpholine L-(+)-tartrate (1:1)
21102-82-9
2233-26-3
238P764
50-58-8
6985IP0T80
A828189
AC1L3R57
AC1Q5R36
Adipost
ALPHAZINE
Bontril (TN)
BONTRIL PDM
CAM-METRAZINE
D-3,4-Dimethyl-2-phenyl-morpholine tartrate
D02080
DI-METREX
DTXSID70198165
EINECS 200-051-0
K631
LS-92795
MELFIAT
MELFIAT-105
Metra
Morpholine, 3,4-dimethyl-2-phenyl-, (+)-, tartrate (1:1)
Morpholine, 3,4-dimethyl-2-phenyl-, (+)-, tartrate (1:1) (8CI)
Morpholine, 3,4-dimethyl-2-phenyl-, (2S-trans)-, (R-(R*,R*))-2,3-dihydroxybutanedioate (1:1)
Morpholine, 3,4-dimethyl-2-phenyl-, (2S,3S)-, (2R,3R)-2,3-dihydroxybutanedioate (1:1)
Morpholine, 3,4-dimethyl-2-phenyl-, tartrate, D-
PHENAZINE-35
Phendimetrazine hydrogen tartrate
Phendimetrazine tartrate (USP)
Phendimetrazine tartrate [USAN]
Phendimetrazine tartrate [USP]
phendimetrazine tartrate, (2S-trans(R-(R*,R*)))-isomer
Prelu 2
Prelu-2
SCHEMBL160375
Sodium alginate, viscosity ~100mp.s
SPRX
SPRX-105
SPRX-3
Statobex
STATOBEX-G
UNII-6985IP0T80
X-TROZINE L.A
X-trozine L.A.

US Patents and Regulatory Information for phendimetrazine tartrate

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Vitarine PHENDIMETRAZINE TARTRATE phendimetrazine tartrate CAPSULE;ORAL 085634-001 Approved Prior to Jan 1, 1982 DISCN No No   Start Trial   Start Trial   Start Trial
Watson Labs PHENDIMETRAZINE TARTRATE phendimetrazine tartrate TABLET;ORAL 085768-001 Approved Prior to Jan 1, 1982 DISCN No No   Start Trial   Start Trial   Start Trial
Barr PHENDIMETRAZINE TARTRATE phendimetrazine tartrate TABLET;ORAL 083684-001 Approved Prior to Jan 1, 1982 DISCN No No   Start Trial   Start Trial   Start Trial
Ferndale Labs ADPHEN phendimetrazine tartrate TABLET;ORAL 083655-001 Approved Prior to Jan 1, 1982 DISCN No No   Start Trial   Start Trial   Start Trial
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Exclusivity Expiration

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Mallinckrodt
Harvard Business School
Boehringer Ingelheim
AstraZeneca
Moodys
McKinsey

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.